Phreesia, Inc. (NYSE:PHR) Receives Consensus Rating of “Buy” from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have earned a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the company, Marketbeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is $31.00.

PHR has been the topic of a number of research analyst reports. JMP Securities reiterated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Needham & Company LLC restated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research note on Friday, January 10th. Truist Financial boosted their price objective on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th. Citigroup boosted their price objective on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Finally, KeyCorp boosted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 8th.

Insider Transactions at Phreesia

In related news, COO Evan Roberts sold 2,873 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total value of $76,450.53. Following the completion of the sale, the chief operating officer now directly owns 779,993 shares of the company’s stock, valued at $20,755,613.73. The trade was a 0.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Michael Weintraub sold 15,152 shares of the business’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $21.01, for a total value of $318,343.52. Following the completion of the sale, the director now directly owns 242,827 shares of the company’s stock, valued at approximately $5,101,795.27. This represents a 5.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 131,756 shares of company stock valued at $3,244,909. 5.80% of the stock is currently owned by insiders.

Institutional Trading of Phreesia

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Champlain Investment Partners LLC increased its holdings in Phreesia by 4.1% in the third quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company’s stock valued at $57,062,000 after buying an additional 97,847 shares during the last quarter. Franklin Resources Inc. boosted its stake in Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock valued at $31,495,000 after acquiring an additional 42,973 shares during the period. State Street Corp boosted its stake in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock valued at $30,256,000 after acquiring an additional 88,517 shares during the period. Geode Capital Management LLC boosted its stake in Phreesia by 4.7% in the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after acquiring an additional 55,934 shares during the period. Finally, TimesSquare Capital Management LLC boosted its stake in Phreesia by 2.3% in the third quarter. TimesSquare Capital Management LLC now owns 868,409 shares of the company’s stock valued at $19,791,000 after acquiring an additional 19,395 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Price Performance

Shares of Phreesia stock opened at $27.29 on Thursday. Phreesia has a twelve month low of $17.07 and a twelve month high of $29.16. The stock has a market capitalization of $1.59 billion, a P/E ratio of -18.56 and a beta of 0.94. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The business’s fifty day moving average price is $23.77 and its 200 day moving average price is $22.94.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter last year, the firm earned ($0.58) earnings per share. The firm’s revenue for the quarter was up 16.6% compared to the same quarter last year. As a group, research analysts anticipate that Phreesia will post -1.1 earnings per share for the current year.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.